PRODUCTION OF MONOCLONAL-ANTIBODIES AGAINST THE HUMAN ANAPHYLATOXIN-C5A DES ARG AND THEIR APPLICATION IN THE NEOEPITOPE-SPECIFIC SANDWICH-ELISA FOR THE QUANTIFICATION OF C5A DES ARG IN PLASMA

被引:30
作者
BERGH, K [1 ]
IVERSEN, OJ [1 ]
机构
[1] SINTEF UNIMED,TRONDHEIM,NORWAY
关键词
C5A DES ARG; COMPLEMENT ACTIVATION; ELISA; MONOCLONAL ANTIBODY;
D O I
10.1016/0022-1759(92)90091-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A panel of ten murine monoclonal antibodies (MAbs) was raised against the human anaphylatoxin C5a des Arg. The MAbs were shown to abrogate or significantly inhibit the chemotactic activity in zymosan activated serum. MAb 4A2E10E2 and MAb 3G3C4 were used as capture and detecting antibody, respectively, in a sandwich enzyme-linked immunosorbent assay (ELISA) for the quantification of C5a des Arg. This ELISA was shown to be very sensitive (detection limit 20 pg/ml) and could be applied directly to plasma/serum samples. The lack of interference by plasma components, in particular C5, suggested specificity for an epitope on C5a (des Arg) which is concealed in native C5 and exposed on the activation fragment only, i.e., a 'neoepitope'. The mean C5a des Arg level in EDTA-plasma from 25 healthy individuals assessed at a 1/20 dilution was 11.2 ng/ml (SD 3.4; range 6.4-16.8 ng/ml). The applicability of the assay was investigated in patients treated with haemodialysis using different membranes. Markedly elevated plasma levels of C5a des Arg were found in blood returning from the dialyzer following contact with cuprophane membranes.
引用
收藏
页码:79 / 87
页数:9
相关论文
共 29 条
[1]   MONOCLONAL-ANTIBODIES AGAINST THE MAJOR ZYMOSAN-INDUCED CHEMOTACTIC FACTOR IN RABBIT SERUM [J].
BERGH, K ;
IVERSEN, OJ ;
AASBAKK, K .
JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 108 (1-2) :179-187
[2]   MEASUREMENT OF COMPLEMENT ACTIVATION IN RABBIT PLASMA OR SERUM USING MONOCLONAL-ANTIBODIES AGAINST C5A [J].
BERGH, K ;
IVERSEN, OJ .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1989, 29 (03) :333-341
[3]   COMPLEMENT ACTIVATION AND PULMONARY DYSFUNCTION IN EXPERIMENTAL ESCHERICHIA-COLI SEPTICEMIA [J].
BERGH, K ;
OLSEN, PO ;
HALGUNSET, J ;
IVERSEN, OJ .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1991, 35 (03) :267-274
[4]  
BHAKDI S, 1988, J IMMUNOL, V141, P3117
[5]   ANAPHYLATOXIN INACTIVATOR OF HUMAN PLASMA - ITS ISOLATION AND CHARACTERIZATION AS A CARBOXYPEPTIDASE [J].
BOKISCH, VA ;
MULLEREB.HJ .
JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (12) :2427-&
[6]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[7]  
Engvall E, 1980, Methods Enzymol, V70, P419
[8]  
FERNANDEZ HN, 1978, J IMMUNOL, V120, P109
[9]  
GERARD NP, 1989, J BIOL CHEM, V264, P1760
[10]  
HAMMERSCHMIDT DE, 1980, LANCET, V1, P947